{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:08:04Z","timestamp":1747163284526,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaclp.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:44:57Z","timestamp":1725381897000},"page":"112-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Substance Use Disorders Among Patients With Psoriasis and Comorbid Major Depressive Disorder"],"prefix":"10.1016","volume":"66","author":[{"given":"Xiaofeng","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1426-474X","authenticated-orcid":false,"given":"James Alan","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2024.08.008_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jad.2020.09.108","article-title":"Major depressive disorder increased risk of psoriasis: a propensity score matched cohort study","volume":"278","author":"Chen","year":"2021","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaclp.2024.08.008_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jad.2020.01.141","article-title":"Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis","volume":"266","author":"Hunt","year":"2020","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jaclp.2024.08.008_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaclp.2024.08.008_bib4","first-page":"120","article-title":"Increased prevalence of alcohol use disorder (AUD) in psoriasis and dermatitis (eczema)","volume":"19","author":"Taneja","year":"2021","journal-title":"Skinmed"},{"key":"10.1016\/j.jaclp.2024.08.008_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaclp.2021.04.008","article-title":"Psychocutaneous medicine clinic: Wisconsin experience","volume":"62","author":"Mostaghimi","year":"2021","journal-title":"J\u00a0Acad Consult Liaison Psychiatry"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T21:44:10Z","timestamp":1741643050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296024000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2667296024000909"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.08.008","relation":{},"ISSN":["2667-2960"],"issn-type":[{"type":"print","value":"2667-2960"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Substance Use Disorders Among Patients With Psoriasis and Comorbid Major Depressive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}